Prevalence of NCD Risk Factors in Kazakhstan

CompletedOBSERVATIONAL
Enrollment

20,400

Participants

Timeline

Start Date

October 23, 2021

Primary Completion Date

August 20, 2022

Study Completion Date

August 20, 2022

Conditions
Non-Communicable Chronic Diseases
Interventions
DIAGNOSTIC_TEST

Blood test

Glucose Glycosylated hemoglobin Triglycerides Total cholesterol HDL Cholesterol LDL Cholesterol Creatinine COVID-19 Antibody IgM to N protein SARS-Cov-2 (Abbott) COVID-19 Antibody IgG to N protein SARS-Cov-2 (Abbott)

DIAGNOSTIC_TEST

STEPwise Approach to NCD Risk Factor Surveillance (STEPS)

The WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) is a simple, standardized method for collecting, analysing and disseminating data on key NCD risk factors in countries. The survey instrument covers key behavioral risk factors: tobacco use, alcohol consumption, physical activity, unhealthy diet, as well as key biological risk factors: overweight and obesity, raised blood pressure, raised blood glucose, and abnormal blood lipids. Through the use of expanded modules, the survey instrument can be expanded to cover a range of topics beyond these risk factors, such as oral health, sexual health and road safety.

DIAGNOSTIC_TEST

Spirometry

Spirometry is a common office test used to assess how well your lungs work by measuring how much air you inhale, how much you exhale and how quickly you exhale.

Trial Locations (1)

050020

Kazakhstan, Almaty

All Listed Sponsors
lead

Asfendiyarov Kazakh National Medical University

OTHER

NCT05122832 - Prevalence of NCD Risk Factors in Kazakhstan | Biotech Hunter | Biotech Hunter